MacTel (Macular Telangiectasia) Type 2
1 clinical trials · Condition
◉ Watch MacTel (Macular Telangiectasia) Type 2
| Record | Firm | Date |
|---|---|---|
| Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel) (NCT03071965) | Neurotech Pharmaceuticals | 2017-05-12 |
Track MacTel (Macular Telangiectasia) Type 2 automatically
Every clearance here is in the API, with alerts when new ones post.